EXOZYMES officer files initial insider Form 3

EXOZYMES INC. reported that Chief Commercial Officer Perriman Damien Alan filed an initial Form 3 as an officer of the company.

Rhea-AI Filing Summary

EXOZYMES INC. reported that Chief Commercial Officer Perriman Damien Alan filed an initial Form 3 as an officer of the company. This filing establishes his status as an insider subject to ongoing ownership and transaction reporting requirements, but it does not list any current holdings or transactions.

Key Terms

Form 3, insider, derivative securities

3 terms

Form 3 regulatory

"filed an initial Form 3 as an officer of the company"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

insider regulatory

"establishes his status as an insider subject to ongoing ownership"

derivative securities financial

"does not list options, warrants, or other derivative securities"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the EXOZYMES INC. (EXOZ) Form 3 for Perriman Damien Alan show?

The Form 3 shows that Perriman Damien Alan is a Chief Commercial Officer of EXOZYMES INC. It is an initial insider ownership report and, in this case, does not list any specific holdings or transactions.

Did the EXOZ Form 3 disclose any share purchases or sales by Perriman Damien Alan?

No, the Form 3 for EXOZ indicates no reported transactions. All transaction-related counts, including buy, sell, exercise, gifts, and tax withholding, are shown as zero in the summary data.

Does the EXOZ Form 3 indicate any derivative positions for Perriman Damien Alan?

No, the filing’s derivative summary is empty, and derivativeTransactionCount is zero. This means the Form 3 does not list options, warrants, or other derivative securities for this reporting person.

What is the role of Perriman Damien Alan at EXOZYMES INC. in this Form 3?

The Form 3 identifies Perriman Damien Alan as an officer of EXOZYMES INC., with the title Chief Commercial Officer. This status subjects him to ongoing insider reporting obligations under SEC rules.

Does this EXOZ Form 3 suggest any change in ownership by the officer?

The Form 3 does not show any change in ownership because all transaction counts and share amounts are zero. It primarily serves as an initial registration of his insider status with the SEC.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/08/2026 - 07:20 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Perriman Damien Alan

(Last) (First) (Middle)

C/O 750 ROYAL OAKS DRIVE,

SUITE 106

(Street)

SAN DIEGO CALIFORNIA 92104

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2026

3. Issuer Name and Ticker or Trading Symbol
EXOZYMES INC. [ EXOZ ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Damien Perriman	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)